Tender Details

Country: Canada
Summary: Duodote Autoinjector (W6369-23A004/A)
CAT Ref No: 68414746
Deadline: 15 Jul 2022
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: W6369-23A004/A
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Tender are invited for Trade Agreement: CETA/WTO-AGP/CPTPP/CFTA/FTAs with Peru/Colombia/Panama/Korea/UKTendering Procedures: Generally only one firm has been invited to bidNon-Competitive Procurement Strategy: Exclusive RightsComprehensive Land Claim Agreement: NoVendor Name and Address: Meridian Medical Technologies, Inc.6350 Stevens Forest RoadSuite 301Columbia MarylandUnited States21046Nature of Requirements: 1. Definition of the requirement The Department of National Defence (DND) has a requirement for the supply of a dual autoinjector containing atropine and pralidoxime chloride to provide treatment of intoxication resulting from suspected exposure to chemical nerve agents or poisoning by a pesticide. 2. Criteria for assessment of the Statement of Capabilities (Minimum Essential Requirements) Any interested supplier must demonstrate by way of a statement of capabilities that its product meets the following requirements: a) The product must have regulatory approval from the US Food and Drug Administration (FDA) or Health Canada.b) The product must have an indication for the treatment of poisoning/intoxication resulting from exposure to organophosphorus nerve agents.c) The product must come in a self-contained single use autoinjector device capable of administering an intramuscular dose.d) Each autoinjector must contain 2.1mg atropine and 600mg pralidoxime chloride.e) All packaging of the product must be labelled in accordance with the direction of the approving regulatory...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Duodote Autoinjector (W6369-23A004/A) - Canada Tender

The PUBLIC WORKS AND GOVERNMENT SERVICES CANADA, a Government sector organization in Canada, has announced a new tender for Duodote Autoinjector (W6369-23A004/A). This tender is published on CanadaTenders under CAT Ref No: 68414746 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2022-07-15.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.